Parental anxiety 2026-10-25
Anxiety experienced by a parent, distinguished from the child's symptoms and from parental accommodation. It may affect burden and participation, but association with child difficulty does not establish that treating it necessarily augments child treatment.[ref]
Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis by Cathy Creswell and others. Health Technology Assessment 19(38); 211-family trial, maternal CBT and mother–child interaction arms
Journal of the American Academy of Child and Adolescent Psychiatry 59, 362–372; SPACE noninferiority trial, ages 7–14 and accommodation outcomes.
Caregivers may facilitate access and practice, receive information, change accommodation, or receive treatment for their own difficulties. These roles imply different mechanisms and should be compared against the same adequate child treatment when testing augmentation. Parent-only treatment and adding parent sessions to child treatment answer different questions.[ref]
A randomized controlled trial of internet-delivered cognitive behaviour therapy for adolescent anxiety disorders in a routine clinical care setting with and without parent sessions by Polly Waite and others. Child and Adolescent Mental Health 24, 242–250; randomised parent-session allocation, primary remission and follow-up
Parents should have a negotiated, formulation-led role that helps an adolescent undertake effective treatment while supporting increasing autonomy. Three roles must be distinguished: facilitating access and practice, changing parental responses that maintain avoidance, and receiving treatment for the parent's own difficulties. A parent being present in more sessions is not a mechanism in itself. The relevant question is which parental action changes which maintaining process, for which adolescent, beyond the effects of adolescent treatment alone.
Initial assessment should obtain both the young person's and caregiver's perspectives on feared situations, avoidance, impairment and family responses. Separate discussion with the adolescent can reveal difficulties they would not disclose in a joint meeting. A shared formulation can then identify whether parents provide repeated reassurance, take over social interactions or organise routines around avoidance. Accommodation can bring immediate relief while reducing opportunities for the adolescent to learn that uncertainty and distress are manageable. Support can instead combine recognition of distress with confidence in the young person's capacity to approach an agreed activity. These descriptions concern potentially modifiable interactions, rather than assigning parental blame for the disorder's origin.
The role should fit developmental circumstances. A thirteen-year-old dependent on a caregiver for transport may need different practical support from a seventeen-year-old arranging appointments. Parents can help implement between-session practice, notice approach rather than merely the disappearance of distress, and support school coordination. The adolescent should help decide what information is shared and which sessions are joint, within clearly explained confidentiality and safeguarding arrangements. Parent involvement can undermine treatment if it becomes surveillance, coercion or another route for excessive reassurance. Fathers, other caregivers and relevant family relationships should be considered rather than assuming that the mother is always the appropriate participant.
Adolescent-specific evidence does not support mandatory additional parent sessions for everyone. Polly Waite and colleagues randomised sixty thirteen- to eighteen-year-olds in routine services to immediate or delayed Internet CBT, with an additional random allocation of parent sessions. The parent addition did not significantly improve remission, either immediately or at follow-up, and the online programme itself did not clearly outperform waiting list on the primary remission endpoint. Confidence intervals were wide. This is evidence against assuming a reliable benefit from that particular addition, rather than proof that parental involvement is useless or that a modest targeted effect is impossible.[ref]
A randomized controlled trial of internet-delivered cognitive behaviour therapy for adolescent anxiety disorders in a routine clinical care setting with and without parent sessions by Polly Waite and others. Child and Adolescent Mental Health 24, 242–250; randomised parent-session allocation, primary remission and follow-up
Evidence from younger samples suggests hypotheses about selection. Vanessa E. Cobham and colleagues stratified families by parental anxiety before randomising sixty-seven seven- to fourteen-year-olds to child CBT with or without parental anxiety management. Their findings suggested greater benefit of the addition when a parent was anxious, but results varied across measures. The study motivates a moderator hypothesis; its small subgroups and younger participants limit a general rule for adolescent treatment.[ref]
The role of parental anxiety in the treatment of childhood anxiety by Vanessa E. Cobham and others. Journal of Consulting and Clinical Psychology 66, 893–905; parental-anxiety strata and parent anxiety-management addition
A larger test cautions against treating a plausible family risk factor as an established augmentation target. Cathy Creswell and colleagues studied 211 children whose mothers also had anxiety disorders. All received child CBT; additions targeted either maternal anxiety or mother–child interaction, with nonspecific contact balanced. The additions changed some maternal outcomes but did not clearly improve the primary child diagnostic outcome. Treating a parent's anxiety may be worthwhile for that parent without necessarily producing an incremental child-treatment effect. Family-risk association, target engagement and improvement in the child's disorder are separate evidential steps.[ref]
Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis by Cathy Creswell and others. Health Technology Assessment 19(38); 211-family trial, maternal CBT and mother–child interaction arms
An alternative is parent-based treatment rather than parental augmentation of child therapy. Eli R. Lebowitz and colleagues randomised 124 seven- to fourteen-year-olds to child CBT or SPACE treatment, a parent intervention reducing accommodation without direct child–therapist sessions. SPACE treatment met prespecified noninferiority criteria for anxiety outcomes and reduced accommodation. This supports the possibility that changing caregiver responses can be an effective delivery route. It does not establish that replacing adolescent-focused therapy with parent work is appropriate across the older teenage years, or that the same approach is preferred by every young person.[ref]
Parent-Based Treatment as Efficacious as Cognitive-Behavioral Therapy for Childhood Anxiety: A Randomized Noninferiority Study of Supportive Parenting for Anxious Childhood Emotions by Eli R. Lebowitz and others. Journal of the American Academy of Child and Adolescent Psychiatry 59, 362–372; SPACE treatment noninferiority trial, ages 7–14 and accommodation outcomes
Together, these studies favour flexible involvement. A useful clinical formulation can identify practical support needs, accommodation that interferes with learning, and parental anxiety requiring its own assessment. However, personalised selection rules remain hypotheses unless prospectively tested. Neither a null augmentation trial nor a successful parent-only trial settles the optimal dose of parent contact alongside a given adolescent therapy. Treatment fidelity also matters: a nominally parent-inclusive programme may differ greatly in whether it rehearses supportive responses, changes accommodation or merely provides information.
A future study should therefore recruit adolescents with diagnosed anxiety across routine services and deliver the same adequate adolescent CBT in every arm. Randomise caregivers to a brief accommodation-focused module or a credible contact-matched education condition; an additional prespecified stratum could examine parents with their own anxiety disorder. Measure accommodation and parental anxiety before allocation, and power the study for the specific treatment-by-baseline-characteristic interactions rather than searching retrospectively for successful subgroups. Include age, caregiver availability and adolescent preference in recruitment and reporting without treating chronological age as a complete measure of autonomy.
Masked diagnostic interviews, young-person-rated impairment and school or social functioning should be assessed after treatment and at six and twelve months. Parent reports should be retained as a separate perspective, not substituted for adolescent outcomes. Record what parents actually do through agreed observations or structured practice tasks, alongside session attendance and treatment fidelity. Measure changes in accommodation repeatedly before the proposed downstream improvement. Temporal mediation would constrain a mechanism, although additional mediator–outcome assumptions would still be needed for a causal mediation claim.
The trial should also measure family burden, acceptability and any deterioration in relationships, and examine families unable to attend conventional sessions. An approach that improves completer outcomes while excluding caregivers with work or language barriers may reduce practical access. Qualitative interviews can explain why a module helps or fails, while the randomised contrast estimates its incremental effect. The 2022 evidence supports parents as potential partners, change agents and recipients of care, but supports a collaboratively chosen and testable role more strongly than indiscriminate intensification of parental attendance.
Exposure should optimise durable approach and new learning about feared outcomes, rather than merely maximise distress or make anxiety disappear within a session. A child who approaches a dog, attends class or speaks to an unfamiliar person has an opportunity to test a prediction. The relevant outcome is whether learning transfers to everyday situations and reduces impairment. What counts as an informative exposure therefore depends on the individual formulation, developmental understanding and actual safety of the situation.
There is direct evidence that exposure can help young people. Thomas H. Ollendick and colleagues randomised 196 seven- to sixteen-year-olds with specific phobias to a concentrated one-session exposure treatment, education-support or waiting list. Exposure produced better diagnostic and behavioural outcomes than the comparison conditions, with follow-up beyond the immediate treatment session. Its behavioural assessment brought the feared situation into the evaluation rather than relying exclusively on a questionnaire. This supports exposure for specific phobias, but neither the single-session format nor its optimal ingredients can automatically be generalised to every adolescent anxiety disorder.[ref]
One-session treatment of specific phobias in youth: a randomized clinical trial in the United States and Sweden by Thomas H. Ollendick and others. Journal of Consulting and Clinical Psychology 77, 504–516; 196 youths, exposure, education-support and waiting-list conditions
A useful theoretical distinction is between habituation and inhibitory learning. Habituation accounts emphasise reductions in fear with repeated contact. An inhibitory learning account instead proposes that exposure creates a competing association: the cue need not predict the feared consequence. The original association may remain available, helping explain why fear returns after time or a change of context. Michelle G. Craske and colleagues developed strategies intended to strengthen the alternative learning and its retrieval, including testing explicit threat expectancies and varying exposure contexts. Their 2014 account is a theoretical and translational framework, rather than a definitive randomised comparison of these strategies in anxious children.[ref]
Maximizing exposure therapy: An inhibitory learning approach by Michelle G. Craske and others. Behaviour Research and Therapy 58, 10–23; theoretical framework and illustrative implementation strategies
This distinction changes what a therapist measures. Suppose a young person predicts that briefly speaking in class will reliably cause visible ridicule. Completing the agreed contribution, observing the actual response and reviewing what was learned directly address that prediction. A reduction from high to low distress during rehearsal is less decisive if the young person attributes safety entirely to reading a perfectly memorised script. Conversely, meaningful expectancy change can occur while some distress remains. Necessary protections against genuine harm should be retained: a behavioral experiment is not a reason to expose a pupil to ongoing bullying or to remove a medically necessary precaution.
Clinical process data question a rigid requirement for within-session fear reduction. Jeremy S. Peterman and colleagues examined exposure-related distress ratings in 72 treated youths, with a mean age of about ten and a half. Most hypothesised habituation indices did not predict outcomes after treatment or at one year. These observational findings weaken the assumption that a particular distress-reduction trajectory is a necessary marker of success. They do not randomly compare learning strategies, prove that habituation never matters, or establish inhibitory learning as the only explanation.[ref]
Testing the habituation-based model of exposures for child and adolescent anxiety by Jeremy S. Peterman and others. Journal of Clinical Child and Adolescent Psychology 48, supplement 1, S34–S44; online 2016; exposure-process predictors in 72 treated youths
Development provides another reason to test rather than simply import adult optimisation rules. Siobhan S. Pattwell and colleagues studied conditioned fear learning and extinction across human age groups and conducted parallel mouse experiments. Human participants encountered conditioned cues and extinction trials, with physiological fear indexed by skin conductance; adolescents showed attenuated extinction relative to children and adults under the experimental conditions. The parallel animal work examined developmental differences in fear-related circuitry and plasticity. These are important motivating experiments, but an age-group difference in laboratory extinction is not a clinical trial of exposure, nor a reason to withhold effective treatment from teenagers.[ref]
Altered fear learning across development in both mouse and human by Siobhan S. Pattwell and others. PNAS 109, 16318–16323; human conditioned-fear/extinction experiment and parallel mouse work
Practical optimisation should therefore begin with an understandable, testable prediction. Use concrete language, pictures or behavioural examples when abstract probability questions exceed the child's understanding. Agree a feasible approach task and identify what evidence would count against the prediction. Record what happened, including ambiguous outcomes, without demanding a predetermined reassuring conclusion. Exposure can be graded to make participation possible, but progression should depend on meaningful learning and functioning rather than an inflexible rule that fear must halve before moving on.
safety behaviors require functional assessment. A caregiver repeatedly speaking for a child may prevent the child from discovering that they can manage an interaction. A gradual reduction in that accommodation may improve the experiment. However, a communication aid or accessibility adjustment may make participation possible rather than maintain an irrational threat belief. The same outward action can have different functions. Adolescents should help choose targets and evaluate outcomes; parents can support practice without becoming an additional source of checking or coercion.
Variation across people, settings and occasions is a plausible way to strengthen transfer. Practising a classroom contribution only in a quiet consulting room leaves context-specific learning untested. Follow-up tasks in ordinary settings can assess whether an alternative expectation is retrieved when anxiety returns. Spacing, varied contexts and retrieval prompts are reasonable candidates for investigation, but the 2022 youth evidence does not establish a universal optimum for their timing or combination. Treatment time is also finite: an elaborate preparation routine can displace opportunities for actual approach.
A future factorial trial could compare prediction-focused exposure with a credible standard exposure protocol, and separately compare practice across several contexts with practice concentrated in one setting. Both conditions should receive adequate treatment, comparable therapist time and the same planned number of approach opportunities. The comparison must specify actual therapist behaviour rather than merely relabel identical exercises. Stratify recruitment by developmental stage and presenting disorder, and power the prespecified interactions instead of interpreting an underpowered subgroup null as equivalence.
The primary outcomes should be masked diagnostic status and functional impairment after treatment and at six months. A novel-context behavioral approach task would test transfer; repeated expectancy and distress ratings would examine proposed processes. Record fidelity, completed practice, adverse experiences, acceptability and dropout. If prediction-focused treatment improves outcome without greater within-session distress reduction, this would challenge a strict habituation-success rule. If varying context improves transfer but not immediate fear, that pattern would support the proposed retrieval rationale. Repeated mediator measurements help establish temporal order, while causal mediation still requires assumptions beyond treatment randomisation.
Exposure optimisation in 2022 consequently had a strong clinical foundation and several promising mechanistic hypotheses, but fewer decisive youth component trials. The most defensible approach combines effective, collaborative approach practice with explicit learning goals and tests long-term functioning. Developmental neuroscience, distress trajectories and adult learning theory inform the research questions; they do not by themselves establish the best clinical protocol for every child.
The case for disorder-specific adolescent CBT was promising by 2022, particularly for social anxiety, but a universal claim of established superiority would exceed the evidence. A disorder-specific approach identifies a maintaining mechanism and targets it with a tailored protocol. A generic or transdiagnostic programme can also be individually formulated and include effective exposure. The relevant comparison is therefore between well-delivered, credible alternatives, rather than specialised treatment and an inadequately implemented generic programme.
Social anxiety provides a strong theoretical example. The Clark–Wells account focuses on internally directed attention, negative self-imagery and safety behaviors that distort learning from social encounters. A protocol can directly test these processes through attention shifts, behavioral experiments and feedback. Leigh and colleagues' adolescent conversation experiment supports a role for combined self-focus and safety behaviors, but experimentally affecting a process is distinct from proving that a complete specialised therapy is superior to competent generic CBT.[ref]
Self-focused attention and safety behaviours maintain social anxiety in adolescents: An experimental study by Eleanor Leigh and others. PLOS ONE 16, e0247703; counterbalanced conversations, 57 participants, partner and independent ratings
Jo Magne Ingul and colleagues supplied relevant clinical evidence: 57 adolescents aged thirteen to sixteen were randomised to individual cognitive therapy, group CBT or an attentional placebo. The individual treatment had better outcomes, including at follow-up. However, individual versus group format, opportunities for personalised experiments and other delivery differences accompanied the contrast in therapeutic model. The study supports that particular intervention package, while leaving uncertainty about how much benefit specifically required a disorder-specific formulation.[ref]
A randomized controlled trial of individual cognitive therapy, group cognitive behaviour therapy and attentional placebo for adolescent social phobia by Jo Magne Ingul and others. Psychotherapy and Psychosomatics 83, 54–61; 57 adolescents aged 13–16, randomised treatments and twelve-month follow-up
Martina Nordh and colleagues subsequently randomised 103 ten- to seventeen-year-olds with social anxiety disorder to Internet-delivered CBT or internet supportive therapy. Both included ten youth modules, five parent modules and three video calls. Masked clinician-rated severity at three months favoured CBT, with a between-group effect size of 0.67. Matching the delivery mode and substantial contact makes this more informative than a waiting-list comparison. Yet the comparator was supportive therapy, not equally intensive generic anxiety CBT, and the sample included children as well as adolescents.[ref]
Therapist-Guided Internet-Delivered Cognitive Behavioral Therapy vs Internet-Delivered Supportive Therapy for Children and Adolescents With Social Anxiety Disorder: A Randomized Clinical Trial by Martina Nordh and others. JAMA Psychiatry 78, 705–713; 103 participants aged 10–17, active comparator and masked severity ratings
Other disorders offer a thinner adolescent-specific basis for a broad conclusion. Donna B. Pincus and colleagues' panic-treatment trial involved 26 fourteen- to seventeen-year-olds and compared a specialised CBT package with self-monitoring. It supported feasibility and benefit, with maintained gains, but was too small and used too limited a comparator to establish superiority over a competent generic programme. A plausible mechanism and a successful small trial justify further study rather than treating the comparative question as closed.[ref]
Cognitive-behavioral treatment of panic disorder in adolescence by Donna B. Pincus and others. Journal of Clinical Child and Adolescent Psychology 39, 638–649; PCT-A versus self-monitoring, 26 adolescents aged 14–17
Conversely, broad anxiety CBT has substantial evidence. The Child/Adolescent Anxiety Multimodal Study found benefit across a sample recruited for generalised, separation or social anxiety. Its predominantly younger sample limits adolescent-specific inference, and it was not a head-to-head test of disorder-specific versus generic CBT. Nonetheless, its results prevent assuming that a shared treatment approach is ineffective merely because diagnoses have distinguishable features.[ref]
Several mechanisms could explain an advantage from specialisation. A generic protocol might provide insufficient social exposure or fail to address the attribution that success depended on a safety behavior. Alternatively, the advantage might arise from more individual therapist time, higher treatment competence or better engagement. These explanations imply different improvements to routine care. If better exposure delivery explains the difference, a flexible generic programme might be improved without creating a wholly separate treatment pathway for every diagnosis.
Diagnostic boundaries also complicate the claim. Adolescents often have more than one anxiety problem, and avoidance, threat appraisal and family accommodation can operate across diagnoses. Selecting one principal diagnosis may underrepresent what matters most to the young person. A narrowly applied protocol could overlook depression, developmental needs or realistic peer adversity. However, a transdiagnostic label should not become a reason to ignore a clearly identified maintaining process. An integrated formulation can combine shared treatment principles with disorder-relevant experiments and monitor both primary and secondary difficulties.
Developmental specificity must be distinguished from diagnostic specificity. An adult social anxiety protocol with altered vocabulary is not necessarily adapted to school relationships, caregiver dependence, confidentiality and adolescents' developing self-representations. Likewise, evidence from a ten- to seventeen-year-old sample does not establish identical effects at ten and seventeen. Trials should report age distributions and recruitment contexts, and avoid treating a nonsignificant, underpowered age interaction as proof of equal applicability.
A strong future trial would compare a specialised protocol with a credible, individually formulated generic CBT protocol within the same delivery format. Match therapist time, supervision, opportunities for exposure, outcome-assessment schedules and treatment credibility. Ensure therapists are competent in both approaches, and assess allegiance and fidelity without making one comparator deliberately weak. Recruitment should include prespecified diagnostic strata, especially social anxiety and panic, with enough participants to estimate clinically meaningful differences rather than pool away the very specificity being tested.
Masked diagnostic assessment and functional impairment should be primary outcomes, with youth reports, school or social participation, adverse effects and family burden included. Follow-up should extend beyond immediate symptom change. Analyse participants according to randomised allocation, report attrition transparently and examine the consequences of missing data. Record resource use because a modest benefit may or may not justify a more complex training and referral system. If the policy aim is to justify a simpler generic pathway, a prespecified noninferiority margin is needed rather than interpreting a null superiority test as equivalence.
Mechanistic measures should be taken before the outcome they are proposed to explain. If the specialised protocol changes self-focused attention earlier and improves later functioning, that supports its rationale but does not remove all mediator–outcome confounding. A complementary component experiment could vary the specific technique while holding the surrounding treatment constant. Converging experimental and clinical evidence would strengthen the conclusion more than a therapy's success alone.
The defensible 2022 conclusion is therefore conditional: specialised adolescent social anxiety treatment had encouraging model-based, experimental and clinical support, while other diagnostic and developmental comparisons remained incomplete. Routine treatment should identify and address specific maintaining processes, but the evidence did not make a universal case that every adolescent anxiety disorder required a separate protocol superior to well-delivered, flexible CBT.
Improving access means increasing the proportion of children who receive an effective, acceptable intervention in time, not simply increasing referrals or distributing an app. The pathway includes recognition, deciding that help is needed, finding a service, starting treatment, receiving its active content and obtaining further care when it is insufficient. Parents can influence every stage, while schools and services determine whether practical barriers make that influence effective. Access and clinical benefit should therefore be evaluated together.
Tessa Reardon and colleagues interviewed parents of sixteen seven- to eleven-year-olds identified through schools as having anxiety disorders. The qualitative accounts distinguished recognising a problem, recognising the need for help, contacting professionals and receiving support. This is useful evidence about the pathway and barriers experienced by families. It is not a population estimate of how often each barrier occurs, nor a trial showing that a particular information campaign increases recovery.[ref]
Barriers and facilitators to parents seeking and accessing professional support for anxiety disorders in children: qualitative interview study by Tessa Reardon and others. European Child and Adolescent Psychiatry 27, 1023–1031; interviews with parents of sixteen school-identified children aged 7–11
Recognition can be supported by concrete descriptions of avoidance and impairment rather than assuming caregivers know diagnostic terminology. School and primary-care routes can offer an initial assessment and an explanation of available options. Information alone, however, cannot remove an inaccessible appointment time, transport cost or long waiting list. Services should provide clear referral instructions, choices of contact mode and a way to ask questions without requiring a caregiver to become an expert navigator. Children whose parents cannot participate still need a route to care.
Guided parent-delivered CBT is one approach to increasing treatment capacity. Kerstin Thirlwall and colleagues randomised 194 children to fuller parent guidance, briefer guidance or waiting list. The fuller programme involved four face-to-face and four telephone contacts; the brief version used two of each. Reported recovery from the principal diagnosis was 50%, 39% and 25%, respectively, with clear evidence for the fuller version against waiting list but greater uncertainty for the brief version. Eligibility excluded a current anxiety disorder in the primary caregiver, limiting direct extrapolation to families who may themselves need support.[ref]
Treatment of child anxiety disorders via guided parent-delivered cognitive-behavioural therapy by Kerstin Thirlwall and others. British Journal of Psychiatry 203, 436–444; 194 children, full/brief parent guidance and waiting list; primary-carer eligibility
The mechanism is not simply giving parents a manual. Guidance can help caregivers identify avoidance, plan manageable approach practice and alter accommodation while receiving feedback from a therapist. This can reduce specialist time spent directly with each child, but shifts some work onto families. Literacy, language, working hours, confidence and the caregiver's own mental health may affect participation. Flexible guidance and practical assistance should be built into delivery rather than interpreting failure to complete as parental unwillingness.
Routine-service evidence is important because research-clinic efficacy does not settle implementation. Cathy Creswell and colleagues randomised 136 five- to twelve-year-olds in four NHS services to brief Guided parent-delivered CBT or solution-focused brief therapy. The trial did not establish a clear difference on global clinical improvement, and the economic analysis suggested a possible efficiency advantage with uncertainty. The improvement endpoint should not be relabelled diagnostic remission; nor does a nonsignificant superiority result prove equivalence. The study nevertheless directly addresses a real service choice between active interventions.[ref]
Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial by Cathy Creswell and others. Lancet Psychiatry 4, 529–539; 136 routine-service participants aged 5–12, CGI-I endpoint and economic uncertainty
Digital delivery offers another route, with limits. Maral Jolstedt and colleagues compared therapist-guided Internet CBT with online child-directed play in 131 eight- to twelve-year-olds. Both conditions involved twelve modules and therapist contact. CBT improved the principal anxiety diagnosis more often, with 48% versus 15% no longer meeting that diagnosis at the assessed endpoint. This supports a guided programme with active clinical content and a credible comparator, not the effectiveness of every freely available anxiety app or the elimination of therapist input.[ref]
Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial by Maral Jolstedt and others. Lancet Child and Adolescent Health 2, 792–801; 131 children aged 8–12, internet CBT versus child-directed play
Results should not be assumed to generalise across ages and programmes. Waite and colleagues did not establish clear remission benefits for their routine-service adolescent online programme or its extra parent sessions. Nordh and colleagues found benefits for a different, disorder-specific internet programme for youth social anxiety against active support. These findings favour evaluating a specified treatment and delivery system, rather than treating the internet itself as the active ingredient.[ref]
A randomized controlled trial of internet-delivered cognitive behaviour therapy for adolescent anxiety disorders in a routine clinical care setting with and without parent sessions by Polly Waite and others. Child and Adolescent Mental Health 24, 242–250; randomised parent-session allocation, primary remission and follow-up
[ref]Therapist-Guided Internet-Delivered Cognitive Behavioral Therapy vs Internet-Delivered Supportive Therapy for Children and Adolescents With Social Anxiety Disorder: A Randomized Clinical Trial by Martina Nordh and others. JAMA Psychiatry 78, 705–713; 103 participants aged 10–17, active comparator and masked severity ratings
Parent-only treatment is also distinct from parent-guided child treatment. Lebowitz and colleagues' SPACE treatment trial showed that changing parental accommodation could provide an effective route in a seven- to fourteen-year-old sample without direct child–therapist treatment sessions. It expands the range of possible offers, but does not justify making parental participation the sole gateway for every older adolescent or assuming the same evidence covers all family circumstances.[ref]
Parent-Based Treatment as Efficacious as Cognitive-Behavioral Therapy for Childhood Anxiety: A Randomized Noninferiority Study of Supportive Parenting for Anxious Childhood Emotions by Eli R. Lebowitz and others. Journal of the American Academy of Child and Adolescent Psychiatry 59, 362–372; SPACE treatment noninferiority trial, ages 7–14 and accommodation outcomes
A sensible service model would offer supported, lower-intensity care where appropriate, measure progress and provide timely escalation when improvement is inadequate. Assessment should identify complexity or urgent need that requires a different pathway immediately. Follow-up should include families who discontinue, because apparently good outcomes among completers can conceal exclusion. Remote and in-person options, interpreters, accessible materials and attention to digital privacy can widen participation; access should also be checked among families without reliable devices or private space.
Parents can support referral, appointments and between-session practice, but the child's perspective remains essential. Parent and child reports may differ, particularly for internal fears. For adolescents, involve caregivers in a negotiated way that respects autonomy and explains confidentiality. Supportive accommodation reduction should not remove disability-related adjustments or expose the child to genuine danger. An access intervention that increases coercion or burden may look efficient while reducing acceptability and sustained engagement.
A future implementation trial could randomise schools or primary-care networks to an accessible parent-guided pathway with direct supported referral, versus the existing referral pathway. Cluster allocation can reduce contamination when staff change their practices across a whole site. Both pathways should provide appropriate assessment and escalation. Prespecify the eligible population, measure how many are offered help, start, receive the intended content and improve, and analyse outcomes using the cluster structure rather than treating every child as independently allocated.
The main service endpoint should combine reach with clinically meaningful outcome, accompanied by masked diagnostic follow-up and everyday functioning. Report waiting time, therapist resource use, family time, dropout and six- or twelve-month outcomes. Examine inequalities by deprivation, language, caregiver anxiety and digital access using prespecified comparisons. A programme that reduces therapist hours but transfers an unmanageable burden to parents has not necessarily improved access. The 2022 evidence supports guided parental involvement and selected digital treatments as useful routes, embedded within assessment, support and escalation rather than offered as universal substitutes for care.
For an adult with established obsessive-compulsive disorder, the core psychological recommendation is cognitive behavioral therapy including exposure and response prevention; an SSRI is another established first-line option, with choice and combination guided by impairment, preference, previous response and clinical assessment. There is no single justified prescription from the diagnostic label alone. A recommendation should connect the maintaining process to an intervention and then examine randomized evidence, tolerability and generalizability.
Assessment first distinguishes recurrent obsessions and compulsions from ordinary unwanted thoughts, practical precautions and other causes of repetitive behavior. Compulsions may be covert mental reviewing or neutralizing rather than visible washing or checking. Relevant information includes time consumed, distress, interference, avoidance, insight, concurrent depression, current risk, physical consequences, family responses and previous treatment. A baseline measure such as the Yale-Brown Obsessive Compulsive Scale can track severity, but neither a score nor the content of an intrusive thought replaces an assessment of its meaning and associated behavior.
Paul Salkovskis's cognitive-behavioral formulation distinguishes an intrusion from its appraisal and the responses that can maintain it. An unwanted thought is interpreted as unusually significant or as creating inflated responsibility for preventing harm. Ritualizing, reassurance or avoidance briefly reduces distress. This negative reinforcement makes repetition more likely and prevents learning that the intrusion can pass without neutralization. Attempting perfect certainty can generate still more checking. The target is therefore the response to the intrusion and its appraisal, not a requirement to eliminate all unwanted thoughts before normal life can resume.[ref]
Obsessional-compulsive problems: A cognitive-behavioural analysis by Paul Salkovskis. 1985, responsibility appraisals, cognitive-behavioral model and case material
In exposure and response prevention, therapist and patient agree a hierarchy of relevant situations and feared predictions. Exposure brings the person into contact with an appropriate trigger; response prevention means refraining from the ritual, including covert neutralization and reassurance that would perform the same function. Tasks may be in vivo or, where appropriate, imaginal. For checking, the learning target is tolerating ordinary uncertainty without repeated checking, rather than obtaining an absolute guarantee that nothing bad can happen. Tasks are collaborative and concern ordinary, acceptable uncertainty; genuine hazards are not deliberately created.
The rationale includes both learning that distress can change without ritualizing and testing whether compulsions are necessary. Habituation can occur, but a reduction in fear within every session is not the sole criterion of learning. An inhibitory learning interpretation emphasizes a new association between the cue and a nonritualized outcome that competes with the old threat expectation. Varying situations and planning practice between sessions can support retrieval of that learning outside the therapy room. Cognitive procedures address overestimation of threat, responsibility and the assumed significance of thoughts; they should facilitate behavioral learning rather than become endless reassurance.[ref]
Maximizing exposure therapy: An inhibitory learning approach by Michelle G. Craske and others. 2014, inhibitory-learning rationale, expectancy violation and retrieval across contexts
Randomized evidence supports this emphasis. Edna B. Foa and colleagues compared intensive exposure and ritual prevention, clomipramine, their combination and pill placebo in a trial with 122 adult entrants. All active conditions outperformed placebo, and exposure-based treatment performed better than clomipramine alone. Combining clomipramine with exposure did not clearly outperform exposure alone. This supports an effective psychological treatment, but does not establish that adding any medication is always useless: the comparison involved a particular drug, intensive expert-delivered exposure, and a particular treatment schedule. Medication could be blinded against placebo; psychological treatment could not be concealed from participants and therapists.[ref]
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder by Edna B. Foa and others. 2005, randomized conditions and acute-treatment results
An SSRI can be offered when preferred, when psychological treatment is inaccessible or difficult to engage with, or as part of combined care. Medication requires prescribing oversight, discussion of adverse effects, interactions and discontinuation, and a sufficient monitored trial before declaring nonresponse. Its effectiveness does not prove that an individual has a simple serotonin deficiency: changing a signaling system is different from establishing the original cause of a disorder.
The pre-examination NICE framework used stepped care: lower-intensity CBT including ERP for suitable mild impairment, a choice of more intensive CBT including ERP or an SSRI for moderate impairment, and combined CBT/ERP plus an SSRI for severe impairment. Inadequate response warrants review of diagnosis, treatment adequacy, engagement and comorbidity, followed by an agreed change or combination; persistent difficulty calls for specialist multidisciplinary assessment. These are severity-sensitive alternatives, not a demand that every adult start with combined treatment or that severity can be inferred from one alarming obsession.[ref]
For persistent symptoms despite an adequate serotonin-reuptake inhibitor trial, Helen Blair Simpson and colleagues randomized 100 adults to added exposure and ritual prevention, risperidone or placebo while continuing medication. At eight weeks, exposure-based augmentation produced more clinical response and minimal symptoms than either pill condition; risperidone did not outperform placebo in this trial. This is strong evidence to consider adequate ERP before routine antipsychotic augmentation in comparable patients. It is not proof that antipsychotics never help any subgroup, nor evidence that the result automatically generalizes to untreated first presentations.[ref]
Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder by Helen Blair Simpson and others. 2013, randomized augmentation trial and week-eight outcomes
Practical delivery matters. Family accommodation can unintentionally maintain rituals; with agreement, carers can support ordinary activities without supplying repeated reassurance or completing compulsions. Outcomes should include functioning, valued activities and distress as well as symptom scores. Nonresponse should prompt examination of whether exposure actually occurred and whether subtle rituals continued, rather than blaming the person. A relapse plan identifies early warning signs and maintains independent practice. The best-supported recommendation is accessible, competent CBT/ERP, with an SSRI or combined treatment when indicated by assessment and preference, and structured review rather than automatic escalation.
A parent-based treatment that targets accommodation and supportive responses to a child's anxiety. A randomised trial compared it with child CBT using prespecified noninferiority criteria; the tested age range and margins constrain the conclusion.[ref]
Parent-Based Treatment as Efficacious as Cognitive-Behavioral Therapy for Childhood Anxiety: A Randomized Noninferiority Study of Supportive Parenting for Anxious Childhood Emotions by Eli R. Lebowitz and others. Journal of the American Academy of Child and Adolescent Psychiatry 59, 362–372; SPACE noninferiority trial, ages 7–14 and accommodation outcomes
